It has been proven that glucagon-like peptide-1 receptor (GLP-1R) agonists control blood glucose concentrations through a multitude of mechanisms, such as increased satiety, slow stomach emptying, decreased glucagon secretion, and increased insulin synthesis/secretion
For semaglutide, this could mean less impact on blood sugar regulation or weight management, potentially delaying your progress
*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information
No portion control
In aging heart tissue, liraglutide is reported to activate IRS1/eNOS/PKG pathways, restoring mitochondrial function by improving mitochondrial membrane potential and reducing oxidative stress (Durak and Turan, 2023)
This hormone helps regulate blood sugar levels, promotes insulin secretion, slows gastric emptying, and reduces appetite
